The major CD9 and CD81 molecular partner - Identification and characterization of the complexes

被引:187
作者
Charrin, S
Le Naour, F
Oualid, M
Billard, M
Faure, G
Hanash, SM
Boucheix, C
Rubinstein, E [1 ]
机构
[1] Hop Paul Brousse, INSERM, U268, F-94807 Villejuif, France
[2] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA
[3] Fac Med Vandoeuvre Nancy, Immunol Lab, F-54500 Vandoeuvre Nancy, France
关键词
D O I
10.1074/jbc.M011297200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
By associating with specific partner molecules and with each other, the tetraspanins are thought to assemble multimolecular complexes that may be especially relevant with respect to metastasis. We have previously identified a 135-kDa molecule (CD9P-1) as a major molecular partner of CD9 in cancer cell lines. This molecule was identified, after immunoaffinity purification and mass spectrometry analysis, as the protein encoded by the KIAA1436 gene and the human ortholog of a rat protein known as FPRP. Cross-linking experiments detected a complex of the size of CD9 plus CD9P-1, showing that these glycoproteins directly associate with each other, probably in the absence of any other molecule. The use of chimeric CD9/CD82 molecules revealed the role of the second half of CD9, comprising the large extracellular loop and the fourth transmembrane domain. CD9P-1 was also shown to form separate complexes with CD81 and with an unidentified 175-kDa molecule. It also associated with other tetraspanins under conditions maintaining tetraspanin/tetraspanin interactions. The identification of a protein strongly linked to the tetraspanin web and the production of a specific monoclonal antibody will help to further characterize the role of this "web" under physiological and pathological conditions.
引用
收藏
页码:14329 / 14337
页数:9
相关论文
共 37 条
  • [1] Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression
    Adachi, M
    Taki, T
    Konishi, T
    Huang, CI
    Higashiyama, M
    Miyake, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1397 - 1406
  • [2] ANGELISOVA P, 1994, IMMUNOGENETICS, V39, P249
  • [3] A general approach to the generation of monoclonal antibodies against members of the tetraspanin superfamily using recombinant GST fusion proteins
    Azorsa, DO
    Moog, S
    Cazenave, JP
    Lanza, F
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 229 (1-2) : 35 - 48
  • [4] Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins)
    Berditchevski, F
    Zutter, MM
    Hemler, ME
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1996, 7 (02) : 193 - 207
  • [5] Cajot JF, 1997, CANCER RES, V57, P2593
  • [6] Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO
  • [7] 2-6
  • [8] Association of TM4SF proteins with integrins: Relevance to cancer
    Hemler, ME
    Mannion, BA
    Berditchevski, F
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1287 (2-3): : 67 - 71
  • [9] SUPPRESSION OF CELL MOTILITY AND METASTASIS BY TRANSFECTION WITH HUMAN MOTILITY-RELATED PROTEIN (MRP-1/CD9) DNA
    IKEYAMA, S
    KOYAMA, M
    YAMAOKO, M
    SASADA, R
    MIYAKE, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (05) : 1231 - 1237
  • [10] The gamete fusion process is defective in eggs of Cd9-deficient mice
    Kaji, K
    Oda, S
    Shikano, T
    Ohnuki, T
    Uematsu, Y
    Sakagami, J
    Tada, N
    Miyazaki, S
    Kudo, A
    [J]. NATURE GENETICS, 2000, 24 (03) : 279 - 282